ID   CA-CD437R
AC   CVCL_4Y66
DR   Wikidata; Q54808292
RX   PubMed=12237293;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:88334; AHPN (6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalenecarboxylic acid; CD437).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gln136Ter (c.406C>T); Zygosity=Homozygous (from parent cell line).
CC   Derived from sampling site: Ovary.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0201 ! Caov-3
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 20-05-21; Version: 6
RX   PubMed=12237293; DOI=10.1074/jbc.M204600200;
RA   Holmes W.F., Soprano D.R., Soprano K.J.;
RT   "Elucidation of molecular events mediating induction of apoptosis by
RT   synthetic retinoids using a CD437-resistant ovarian carcinoma cell
RT   line.";
RL   J. Biol. Chem. 277:45408-45419(2002).